These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8609148)

  • 1. Stage-specific gene expression during hepatocarcinogenesis in the rat.
    Pitot HC
    J Cancer Res Clin Oncol; 1996; 122(5):257-65. PubMed ID: 8609148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat: transforming growth factor alpha expression as a marker for the stage of progression.
    Dragan Y; Teeguarden J; Campbell H; Hsia S; Pitot H
    Cancer Lett; 1995 Jun; 93(1):73-83. PubMed ID: 7600545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat.
    Pitot HC; Dragan Y; Sargent L; Xu YH
    Environ Health Perspect; 1991 Jun; 93():181-9. PubMed ID: 1723043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat.
    Sargent L; Dragan Y; Xu YH; Sattler G; Wiley J; Pitot HC
    Cancer Res; 1996 Jul; 56(13):2985-91. PubMed ID: 8674052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adventures in hepatocarcinogenesis.
    Pitot HC
    Annu Rev Pathol; 2007; 2():1-29. PubMed ID: 18039091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the expression of some genes for enzymes of glutathione metabolism in hepatotoxicity and hepatocarcinogenesis.
    Pitot HC; Goodspeed D; Dunn T; Hendrich S; Maronpot RR; Moran S
    Toxicol Appl Pharmacol; 1989 Jan; 97(1):23-34. PubMed ID: 2563599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor (TGF)-beta1 and TGF-beta type II receptor in preneoplastic lesions during chemical hepatocarcinogenesis of rats.
    Park DY; Hwang SY; Suh KS
    Toxicol Pathol; 2001; 29(5):541-9. PubMed ID: 11695571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of multistage carcinogenesis in rat liver.
    Pitot HC; Dragan YP; Teeguarden J; Hsia S; Campbell H
    Toxicol Pathol; 1996; 24(1):119-28. PubMed ID: 8839289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis.
    Dragan YP; Hully J; Crow R; Mass M; Pitot HC
    Carcinogenesis; 1994 Sep; 15(9):1939-47. PubMed ID: 7923588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes.
    Sargent LM; Sanderson ND; Thorgeirsson SS
    Cancer Res; 1996 May; 56(9):2137-42. PubMed ID: 8616862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression during multistage hepatocarcinogenesis.
    Pitot HC; Beer DG; Hendrich S
    Scand J Gastroenterol Suppl; 1988; 151():52-61. PubMed ID: 3227317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of DRH strain rats to chemical carcinogenesis of liver: genetic analysis of later progression stage.
    Yan Y; Zeng ZZ; Higashi S; Denda A; Konishi Y; Onishi S; Ueno H; Higashi K; Hiai H
    Carcinogenesis; 2002 Jan; 23(1):189-96. PubMed ID: 11756240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of experimental and theoretical parameters of the Moolgavkar-Venzon-Knudson incidence function for the stages of initiation and promotion in rat hepatocarcinogenesis.
    Dragan YP; Hully J; Baker K; Crow R; Mass MJ; Pitot HC
    Toxicology; 1995 Sep; 102(1-2):161-75. PubMed ID: 7482551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrative analysis of chemically-induced cirrhosis-associated hepatocarcinogenesis: Histological, biochemical and molecular features.
    Romualdo GR; Grassi TF; Goto RL; Tablas MB; Bidinotto LT; Fernandes AAH; Cogliati B; Barbisan LF
    Toxicol Lett; 2017 Nov; 281():84-94. PubMed ID: 28943392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat.
    Pitot HC; Campbell HA; Maronpot R; Bawa N; Rizvi TA; Xu YH; Sargent L; Dragan Y; Pyron M
    Toxicol Pathol; 1989; 17(4 Pt 1):594-611; discussion 611-2. PubMed ID: 2697939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology of early stage chemically induced hepatocarcinogenesis.
    Ogawa K
    Pathol Int; 2009 Sep; 59(9):605-22. PubMed ID: 19712128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of transforming growth factor alpha and prostaglandins in preferential growth of preneoplastic rat hepatocytes.
    Hufnagl K; Parzefall W; Marian B; Käfer M; Bukowska K; Schulte-Hermann R; Grasl-Kraupp B
    Carcinogenesis; 2001 Aug; 22(8):1247-56. PubMed ID: 11470756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.
    De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F
    Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular distributions of molecules with altered expression specific to the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
    Takahashi M; Shibutani M; Woo GH; Inoue K; Fujimoto H; Igarashi K; Kanno J; Hirose M; Nishikawa A
    Carcinogenesis; 2008 Nov; 29(11):2218-26. PubMed ID: 18586688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.